These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767 [TBL] [Abstract][Full Text] [Related]
5. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Muzik O; da Silva EA; Juhasz C; Chugani DC; Shah J; Nagy F; Canady A; von Stockhausen HM; Herholz K; Gates J; Frost M; Ritter F; Watson C; Chugani HT Neurology; 2000 Jan; 54(1):171-9. PubMed ID: 10636144 [TBL] [Abstract][Full Text] [Related]
6. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004 [TBL] [Abstract][Full Text] [Related]
7. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy. Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis. Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833 [TBL] [Abstract][Full Text] [Related]
10. Performance of PET imaging for the localization of epileptogenic zone in patients with epilepsy: a meta-analysis. Niu N; Xing H; Wu M; Ma Y; Liu Y; Ba J; Zhu S; Li F; Huo L Eur Radiol; 2021 Aug; 31(8):6353-6366. PubMed ID: 33523306 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778 [TBL] [Abstract][Full Text] [Related]
13. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? Debets RM; Sadzot B; van Isselt JW; Brekelmans GJ; Meiners LC; van Huffelen AO; Franck G; van Veelen CW J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):141-50. PubMed ID: 9048714 [TBL] [Abstract][Full Text] [Related]
14. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Juhász C; Chugani DC; Muzik O; Shah A; Shah J; Watson C; Canady A; Chugani HT Neurology; 2001 Jun; 56(12):1650-8. PubMed ID: 11425929 [TBL] [Abstract][Full Text] [Related]
15. [Functional imaging (PET and SPECT) in epilepsy]. Borbély K Orv Hetil; 2001 Nov; 142(44):2405-14. PubMed ID: 11766233 [TBL] [Abstract][Full Text] [Related]
16. Perfusion SPECT, SISCOM and PET (18)F-FDG in the assessment of drug- refractory epilepsy patients candidates for epilepsy surgery. Suárez-Piñera M; Mestre-Fusco A; Ley M; González S; Medrano S; Principe A; Mojal S; Conesa G; Rocamora R Rev Esp Med Nucl Imagen Mol; 2015; 34(6):350-7. PubMed ID: 26118354 [TBL] [Abstract][Full Text] [Related]